Impact of a patient-centered tool to reduce misconceptions about coronary artery disease and its treatment: The CAD roadmap.
PEC Innov
; 4: 100303, 2024 Dec.
Article
en En
| MEDLINE
| ID: mdl-38911020
ABSTRACT
Objective:
Health misinformation is common and can lead to harmful behaviors such as medication non-adherence. We assessed the impact of a novel patient educational tool focused on overcoming misconceptions among patients with coronary artery disease (CAD).Methods:
We developed the CAD Roadmap, an educational tool aimed at explaining the disease trajectory and overcoming common disease misconceptions (such as that statin medications are not beneficial). We designed a pilot survey to assess patients' 1) CAD-related knowledge, 2) medication-taking behavior, and 3) acceptability of the Roadmap. Survey participants were recruited online. CAD knowledge scores were compared with repeated measures t-tests.Results:
Among 114 patients with CAD (mean age 67 years, 63% male), average CAD-related knowledge was 79.0% pre-test and 89.7% after review of the CAD Roadmap (p < .001). After review of the Roadmap, 24% indicated they planned to take their medications more regularly, 93% agreed it was helpful in understanding medication benefits, and 77% felt more empowered to participate in medical decisions.Conclusion:
The CAD Roadmap was evaluated positively, improved disease-related knowledge, and has the potential to improve adherence to treatments. Innovation Unlike many other interventions, the CAD Roadmap is specifically designed to overcome common misconceptions to improve health behaviors.
Texto completo:
1
Bases de datos:
MEDLINE
Idioma:
En
Revista:
PEC Innov
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos